Telesis Bio Inc (TBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,010 | -12,427 | -7,962 | -14,282 | -113,293 |
| Depreciation Amortization | 1,744 | 1,257 | 842 | 1,351 | 4,732 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -486 |
| Accounts receivable | N/A | 99 | 354 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -9,545 | 9,928 |
| Other Working Capital | -20 | -400 | -490 | -12,236 | -3,021 |
| Other Operating Activity | 905 | 649 | 401 | 3,265 | 19,978 |
| Operating Cash Flow | $-15,381 | $-10,822 | $-6,855 | $-31,447 | $-82,162 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -27,409 | -174,271 |
| PPE Investments | -204 | -114 | -106 | -2,325 | -3,537 |
| Sale Of Investment | N/A | N/A | N/A | 73,994 | 159,622 |
| Investing Cash Flow | $-204 | $-114 | $-106 | $44,260 | $-18,186 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -82 | -54 | N/A | N/A |
| Common Stock Issued | N/A | 0 | N/A | 132 | 130,720 |
| Other Financing Activity | -96 | 0 | 0 | -57 | -1,066 |
| Financing Cash Flow | $-96 | $-82 | $-54 | $75 | $129,654 |
| Beginning Cash Position | 29,144 | 29,144 | 29,144 | 85,530 | 56,224 |
| End Cash Position | 13,463 | 18,126 | 22,129 | 98,418 | 85,530 |
| Net Cash Flow | $-15,681 | $-11,018 | $-7,015 | $12,888 | $29,306 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,381 | -10,822 | -6,855 | -31,447 | -82,162 |
| Capital Expenditure | N/A | -114 | -106 | -2,325 | -3,537 |
| Free Cash Flow | -15,381 | -10,936 | -6,961 | -33,772 | -85,699 |